发明名称 PHARMACEUTICAL COMPOUNDS
摘要 A pharmaceutical compound of the formula <IMG> (I) in which R1 and R7 are each halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R2 and R3 are each hydrogen or C1-6 alkyl, R4 and R5 are each hydrogen, halo, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl, R6 is hydrogen, C1-6 alkyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted heteroaryl, optionally substituted phenyl-C1-6 alkyl or -CO2R8 where R8 is an ester group, m and p are each 0, 1, 2, 3 or 4, n is 1, 2, 3 or 4, Z is <IMG> , ?O? , ?S? or <IMG> where R9 and R10 are each hydrogen, C1-6 alkyl or optionally substituted phenyl-C1-6 alkyl, X is oxygen or sulphur, and Y is <IMG> or <IMG> where R11 and R12 are each hydrogen, C1-6 alkyl, trifluoromethyl, optionally substituted phenyl, optionally substituted naphthyl or optionally substituted heteroaryl; and salts and solvates thereof.
申请公布号 CA2157998(A1) 申请公布日期 1996.03.13
申请号 CA19952157998 申请日期 1995.09.11
申请人 LILLY INDUSTRIES LIMITED 发明人 GILMORE, JEREMY;GALLAGHER, PETER THADDEUS;MILES, MARTIN VICTOR;OWTON, WILLIAM MARTIN;SMITH, COLIN WILLIAM
分类号 C07D403/04;A61K31/405;A61K31/415;A61K31/4164;A61K31/42;A61K31/425;A61K31/455;A61K31/47;A61P1/00;A61P1/08;A61P3/04;A61P9/00;A61P9/12;A61P13/02;A61P15/00;A61P25/00;A61P25/04;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P25/30;A61P43/00;C07D209/00;C07D413/06;C07D471/04;C07D487/04;(IPC1-7):C07D471/04;A61K31/435 主分类号 C07D403/04
代理机构 代理人
主权项
地址